Probiotic could boost necrotic enteritis control in poultry

A genetically engineered synthetic probiotic could reduce poultry mortality and improve feed conversion against the bacterium Clostridium perfringens, a precursor to necrotic enteritis.

Doughman Headshot3 Headshot
Subscribe to Magazine
David Tadevosian I shutterstock.com
David Tadevosian I shutterstock.com

A genetically engineered synthetic probiotic could reduce poultry mortality and improve feed conversion against the bacterium Clostridium perfringens, a precursor to necrotic enteritis.

“We develop recombinant antimicrobial live therapeutics. You can think of them as probiotics, but they are synthetically engineered so that their activity against pathogens is boosted up,” explained Yiannis Kaznessis, CEO, General Probiotics Inc.

Controlling C. perfringens

The biotherapeutic uses a combination of genetic engineering and synthetic biology techniques to function as an alternative to antibiotics against C. perfringens and necrotic enteritis.

Necrotic enteritis is an acute infection caused by the bacteria C. perfingens. Intestinal damage in poultry allows the bacteria, which is a normal inhabitant of the intestinal tract, to attach, proliferate and produce toxins.

It effectively decreases mortality by 40-70% against C. perfringens in animal tests. In addition, birds that were administered the live therapeutic showed improved feed conversion ratio.

Early research suggests that the biotherapeutic will work against other poultry diseases, including coccidiosis and avian influenza.

Preliminary FDA approval achieved

Presented as an innovation at the 2020 Poultry Tech Summit Webinar Series, General Probiotics recently obtained label claim approval from the Food and Drug Administration (FDA). 

“For the last couple of years, we’ve been working with the FDA’s Center for Veterinary Medicine (CVM) to get approval for what would be the first recombinant live therapeutic for animal health in the U.S. and globally,” Kaznessis added.

General Probiotics is looking for partners to help manufacture the biotherapeutic treatment at a commercial scale and expand testing in commercial poultry facilities.

Attend the 2023 Poultry Tech Summit

Join an exclusive international gathering of industry-changing innovators, researchers, entrepreneurs, technology experts, investors and leading poultry producers at the 2023 edition of Poultry Tech Summit on November 6-8 at the Hilton Atlanta Airport in Atlanta, Georgia

Attendees can expect the same groundbreaking innovation and insightful presentations that made the previous events well-attended with deep dialogue on new prospective solutions and next-generation technologies. Poultry Tech Summit focuses on the transition of innovative technologies into commercial applications to advance the poultry industry.

Registration for this event will open in the spring of 2023.

Subscribe to Magazine
Page 1 of 84
Next Page